SKIN The Journal of Cutaneous Medicine

Del Rosso, James

SKIN The Journal of Cutaneous Medicine Vol. 7 No. 2 (2023): March Issue & Poster Presentations from WCH23 Dermatology Conference® - Atopic Dermatitis
Exposure–Response Analysis Demonstrates Response to Tapinarof is Driven by Local Effects at Sites of Application
Abstract Poster PDF
SKIN The Journal of Cutaneous Medicine Vol. 5 No. 6 (2021): November Issue & Poster Presentations (FC21 Dermatology Conference®) - Acne & Rosacea
Efficacy and Safety of Tazarotene 0.045% Lotion in White Adults with Moderate-to-Severe Acne
Abstract Poster PDF
SKIN The Journal of Cutaneous Medicine Vol. 5 No. 6 (2021): November Issue & Poster Presentations (FC21 Dermatology Conference®) - Acne & Rosacea
Oral Sarecycline for Treatment of Papulopustular Rosacea: Results of a Pilot Study Evaluating Efficacy and Safety
Abstract Poster PDF
SKIN The Journal of Cutaneous Medicine Vol. 6 No. 2 (2022): March Issue and Poster Presentations (FC PANP 21 and WC 22 Dermatology Conferences®) - Acne & Rosacea
Critical Evaluation of Benzoyl Peroxide in Rosacea: Old Challenges and New Clinical Opportunities With Encapsulated Benzoyl Peroxide
Abstract Poster PDF
SKIN The Journal of Cutaneous Medicine Vol. 6 No. 2 (2022): March Issue and Poster Presentations (FC PANP 21 and WC 22 Dermatology Conferences®) - Acne & Rosacea
A New Frontier in Acne Treatment: Encapsulated Benzoyl Peroxide and Tretinoin
Abstract Poster PDF
SKIN The Journal of Cutaneous Medicine Vol. 6 No. 2 (2022): March Issue and Poster Presentations (FC PANP 21 and WC 22 Dermatology Conferences®) - Acne & Rosacea
Fixed-Dose Clindamycin Phosphate 1.2%, Benzoyl Peroxide 3.1%, and Adapalene 0.15% Gel for Moderate-to-Severe Acne: Phase 2 Study of the First Triple-Combination Drug
Abstract Poster PDF
SKIN The Journal of Cutaneous Medicine Vol. 6 No. 6 (2022): November Issue & Poster Presentations from FC22 Dermatology Conference® - Poster Presentations from FC22 Dermatology Conference®: Psoriasis
Exposure–Response Analysis Demonstrates Response to Tapinarof is Driven by Local Effects at Sites of Application
Abstract Poster PDF
SKIN The Journal of Cutaneous Medicine Vol. 4 No. 6 (2020): November Issue & Poster Presentations (FC20 Dermatology Conference®) - Acne & Rosacea
Integrated Efficacy of FMX101 4% Topical Minocycline Foam for the Treatment of Moderate-to-Severe Acne Vulgaris: Analyses of Efficacy in Clinically Relevant Subgroups of Patients
Abstract Poster PDF
SKIN The Journal of Cutaneous Medicine Vol. 7 No. 2 (2023): March Issue & Poster Presentations from WCH23 Dermatology Conference® - Atopic Dermatitis
Lebrikizumab Monotherapy Reduces Flares in Patients with Moderate-to-Severe Atopic Dermatitis
Abstract Poster PDF
SKIN The Journal of Cutaneous Medicine Vol. 7 No. 6 (2023): November 2023 Issue - Atopic Dermatitis
Lebrikizumab Provides Stable Itch Response With No or Minimal Fluctuations up to One Year in Patients With Atopic Dermatitis
Abstract PDF
SKIN The Journal of Cutaneous Medicine Vol. 1 No. 3 (2017) - Therapeutic Tips
Clinically Important Considerations with the Use of Oral Doxycycline
Abstract Full Article PDF
SKIN The Journal of Cutaneous Medicine Vol. 8 No. 2 (2024): March 2024 Issue - Posters from 2024 WCH and WCM Conferences: Psoriasis
Roflumilast Cream 0.3% in Patients With Chronic Plaque Psoriasis: Individual Patient PASI and PASI-HD Responses: Pooled DERMIS-1 and DERMIS-2 Phase 3 Trials
Abstract PDF
SKIN The Journal of Cutaneous Medicine Vol. 7 No. 2 (2023): March Issue & Poster Presentations from WCH23 Dermatology Conference® - Acne & Rosacea
Investigator global assessment (IGA) of Acne Vulgaris and IGA Success among patients with moderate to severe non-nodular Acne Vulgaris (AV) administered sarecycline in community practices across the U.S in PROSES study: Analysis by concomitant medication
Abstract Poster PDF
SKIN The Journal of Cutaneous Medicine Vol. 1 No. 2 (2017) - In-Depth Reviews
Antibiotic Resistance Considerations of Importance to Clinical Dermatologists
Abstract Full Article PDF
SKIN The Journal of Cutaneous Medicine Vol. 8 No. 1 (2024): January 2024 Issue - Poster Presentations from FC23 Dermatology Conference®: Psoriasis
Roflumilast Cream 0.3% in Patients with Chronic Plaque Psoriasis: Individual Patient Response from the Pooled DERMIS-1 and DERMIS-2 Phase 3 Trials
Abstract PDF
SKIN The Journal of Cutaneous Medicine Vol. 8 No. 1 (2024): January 2024 Issue - Editorials
Thank You for 1 Million Reads
Abstract PDF
SKIN The Journal of Cutaneous Medicine Vol. 7 No. 6 (2023): November 2023 Issue - Poster Presentations from FC23 Dermatology Conference®: Psoriasis
Roflumilast Cream 0.3% in Patients With Chronic Plaque Psoriasis: Individual Patient Response From the Pooled DERMIS-1 and DERMIS-2 Phase 3 Trials
Abstract PDF
SKIN The Journal of Cutaneous Medicine Vol. 8 No. 1 (2024): January 2024 Issue - Acne & Rosacea
Clinician Perception of Antibiotics and Antibiotic Resistance in the Context of Managing Acne Vulgaris (AV), and Satisfaction With AV Treatment Outcomes Among Patients Administered Sarecycline in Clinical Practices Across the US: Results from PROSES Study
Abstract PDF
SKIN The Journal of Cutaneous Medicine Vol. 5 No. 6 (2021): November Issue & Poster Presentations (FC21 Dermatology Conference®) - Poster Presentations from FC21 Dermatology Conference®: Psoriasis
Long-term Safety and Efficacy of Fixed-Combination Halobetasol Propionate and Tazarotene Lotion in Patients With Clinically Meaningful Improvement in Plaque Psoriasis
Abstract Poster PDF
SKIN The Journal of Cutaneous Medicine Vol. 1 (2017): Supplemental Issue: Scientific Posters Presented at 2017 Fall Clinical Dermatology Conference®-Las Vegas - Acne & Rosacea
Efficacy and Saftey of Adapalene 0.3%/Benzoyl Peroxide 2.5% Gel Plus Doxycycline in Subjects with Severe Inflammatory Acne (Non-Nodulocystic) that are Candidates for Oral Isotretinoin
Abstract Poster PDF
SKIN The Journal of Cutaneous Medicine Vol. 1 No. 3 (2017) - Fall Clinical Dermatology Conference CME Video Lecture Series
What's New in the Medicine Chest? Part 1
Abstract Video Description (Length-25:03)
SKIN The Journal of Cutaneous Medicine Vol. 2 No. 3 (2018) - Pearls for the Practitioner
Capsule Commentaries: Selected Oral Antifungal Drug-Drug Interactions with Itraconazole and Terbinafine
Abstract Full Article PDF
SKIN The Journal of Cutaneous Medicine Vol. 4 No. 6 (2020): November Issue & Poster Presentations (FC20 Dermatology Conference®) - Acne & Rosacea
Open-Label Extension Study Evaluating the Long-Term Safety, Efficacy, and Tolerability of FMX103 1.5% Topical Minocycline Foam in the Treatment of Moderate-to-Severe Facial Papulopustular Rosacea
Abstract Poster PDF
SKIN The Journal of Cutaneous Medicine Vol. 5 No. 1 (2021): January Issue & Poster Presentations (WC21 Dermatology Conference®) - Dermatopharmacology
Sarecycline Demonstrates Narrow spectrum Antibacterial Activity and Anti inflammatory Effect in Animal Models
Abstract Poster PDF
SKIN The Journal of Cutaneous Medicine Vol. 5 No. 2 (2021) - Clinical Management Recommendations
Considerations in the Management of Actinic Keratosis: The Importance of Adherence and Persistence to Therapy
Abstract PDF
SKIN The Journal of Cutaneous Medicine Vol. 6 No. 2 (2022): March Issue and Poster Presentations (FC PANP 21 and WC 22 Dermatology Conferences®) - Poster Presenations From Winter Clinical 2022 and FC PANP 2021: Psoriasis
Tapinarof Cream 1% Once Daily for Plaque Psoriasis: Efficacy by Baseline Disease Characteristics and Demographics in Two Pivotal Phase 3 Trials
Abstract Poster PDF
SKIN The Journal of Cutaneous Medicine Vol. 7 No. 3 (2023): May Issue and Posters from WCH23 & WCM23 - Original Research
Clinician- and Patient-Reported Outcomes with Tirbanibulin 1% Treatment for Actinic Keratosis in Routine Clinical Practice Across the U.S. (PROAK Study)
Abstract PDF
SKIN The Journal of Cutaneous Medicine Vol. 2 (2018): Supplemental Issue: Scientific Posters Presented at 2018 Winter Clinical Dermatology Conference®-Hawaii - Acne & Rosacea
An Open-Label Study Evaluating the Long-Term Efficacy, Quality of Life, and Safety of Lidose-Isotretinoin (ABSORICA) Capsules Administered Without Food in Patients with Severe Recalcitrant Nodular Acne: Interim Analysis of 20-Week Active Treatment Period
Abstract Poster PDF
SKIN The Journal of Cutaneous Medicine Vol. 1 (2017): Supplemental Issue: Scientific Posters Presented at 2017 Fall Clinical Dermatology Conference®-Las Vegas - Acne & Rosacea
Rapid Improvement with BPX-01 Minocycline Topical Gel in the Treatment of Moderate-to-Severe Inflammatory Acne Vulgaris: a Randomized, Double-Blind, Vehicle-Controlled Study
Abstract Poster PDF
SKIN The Journal of Cutaneous Medicine Vol. 3 (2019): Supplemental Issue: Scientific Posters Presented at 2019 Fall Clinical Dermatology Conference®-Las Vegas - Poster Presentations from FC23 Dermatology Conference®: Psoriasis
Tapinarof Cream for the Treatment of Plaque Psoriasis: Efficacy and Safety by Baseline Disease Characteristics and Skin Type in a Phase 2b Randomized Study
Abstract Poster PDF
SKIN The Journal of Cutaneous Medicine Vol. 4 No. 5 (2020): September Issue & Poster Presentations (FCPANP20® Dermatology Conference) - Acne & Rosacea
Trifarotene 50 µg/G Cream for Treatment of Acne Vulgaris – A Summary of Two Randomized Trials and a Long-Term Safety Study
Abstract Poster PDF
SKIN The Journal of Cutaneous Medicine Vol. 6 No. 2 (2022): March Issue and Poster Presentations (FC PANP 21 and WC 22 Dermatology Conferences®) - Poster Presenations From Winter Clinical 2022 and FC PANP 2021: Psoriasis
Patient Satisfaction with Tapinarof Cream 1% Once Daily for Plaque Psoriasis in a Long-Term Extension Trial
Abstract Poster PDF
SKIN The Journal of Cutaneous Medicine Vol. 6 No. 6 (2022): November Issue & Poster Presentations from FC22 Dermatology Conference® - Poster Presentations from FC22 Dermatology Conference®: Psoriasis
Efficacy and Tolerability of Roflumilast Cream 0.3% in Patients With Chronic Plaque Psoriasis Involvement on the Face, Intertriginous, or Genital Areas: Pooled Results From Phase 3 Trials (DERMIS-1 and DERMIS-2)
Abstract Poster PDF
SKIN The Journal of Cutaneous Medicine Vol. 7 No. 6 (2023): November 2023 Issue - Skin Cancer
Safety and Tolerability of Tirbanibulin 1% Treatment of Actinic Keratosis on Face and Scalp in Routine Clinical Practice Across the U.S. (PROAK Study)
Abstract PDF
SKIN The Journal of Cutaneous Medicine Vol. 5 No. 6 (2021): November Issue & Poster Presentations (FC21 Dermatology Conference®) - Poster Presentations from FC21 Dermatology Conference®: Psoriasis
Tapinarof Cream 1% Once Daily for Plaque Psoriasis: Efficacy by Baseline Disease Characteristics and Demographics in Two Pivotal Phase 3 Trials
Abstract Poster PDF
SKIN The Journal of Cutaneous Medicine Vol. 8 No. 2 (2024): March 2024 Issue - Atopic Dermatitis
Roflumilast Cream 0.15% in Patients with Atopic Dermatitis: Individual Patient Response from the Pooled INTEGUMENT-1 and INTEGUMENT-2 Phase 3 Trials
Abstract PDF
SKIN The Journal of Cutaneous Medicine Vol. 7 No. 3 (2023): May Issue and Posters from WCH23 & WCM23 - Acne & Rosacea
Acne symptoms and impact of acne on social functioning, emotional functioning, and activities of daily living (ADL) among patients with moderate to severe non-nodular Acne Vulgaris (AV) in community practices across the U.S
Abstract Poster PDF
SKIN The Journal of Cutaneous Medicine Vol. 5 No. 6 (2021): November Issue & Poster Presentations (FC21 Dermatology Conference®) - Hyperhidrosis
Investigating Treatment of Primary Axillary Hyperhidrosis With a Topical Retrometabolic Anticholinergic Drug
Abstract Poster PDF
SKIN The Journal of Cutaneous Medicine Vol. 8 No. 1 (2024): January 2024 Issue - Miscellaneous
Avoiding the Danger of Rising Resistance in Cutibacterium acnes: Criticality of Benzoyl Peroxide and Antibiotic Fixed Combinations
Abstract PDF
SKIN The Journal of Cutaneous Medicine Vol. 7 No. 3 (2023): May Issue and Posters from WCH23 & WCM23 - Acne & Rosacea
Clinician satisfaction with treatment outcomes among patients with moderate to severe non-nodular Acne Vulgaris (AV) administered sarecycline in community practices across the U.S in PROSES study: Analysis by concomitant medication use
Abstract PDF
SKIN The Journal of Cutaneous Medicine Vol. 7 No. 3 (2023): May Issue and Posters from WCH23 & WCM23 - Clinical Management Recommendations
The Importance of Medication Adherence in the Treatment of Actinic Keratosis: An Expert Consensus Panel
Abstract PDF
SKIN The Journal of Cutaneous Medicine Vol. 8 No. 1 (2024): January 2024 Issue - Poster Presentations from FC23 Dermatology Conference®: Psoriasis
Investigator- and Patient-Rated Local Tolerability in Phase 3 Trials of Topical Roflumilast in Patients With Psoriasis, Seborrheic Dermatitis, and Atopic Dermatitis
Abstract PDF
SKIN The Journal of Cutaneous Medicine Vol. 7 No. 6 (2023): November 2023 Issue - Poster Presentations from FC23 Dermatology Conference®: Psoriasis
Investigator- and Patient-Rated Local Tolerability in Phase 3 Trials of Topical Roflumilast in Patients With Psoriasis, Seborrheic Dermatitis, and Atopic Dermatitis
Abstract PDF
SKIN The Journal of Cutaneous Medicine Vol. 5 No. 6 (2021): November Issue & Poster Presentations (FC21 Dermatology Conference®) - Poster Presentations from FC21 Dermatology Conference®: Psoriasis
Once-Daily Roflumilast Cream 0.3%, a Potent Phosphodiesterase-4 Inhibitor, Provided Safe and Effective Treatment of Psoriasis in the DERMIS-1 and DERMIS-2 Phase 3 Trials
Abstract Poster PDF
SKIN The Journal of Cutaneous Medicine Vol 2, No 6 (2018) - Original Research
Clinical Efficacy & Safety of Oral Polypodium Leucotomos Extract for Photoprotection: A Systematic Review
Abstract Full Article PDF
SKIN The Journal of Cutaneous Medicine Vol. 8 No. 1 (2024): January 2024 Issue - Acne & Rosacea
Triple-Combination Fixed-Dose Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% for Moderate-to-Severe Acne: Efficacy and Safety Results From a Pooled Phase 3 Analysis
Abstract PDF
SKIN The Journal of Cutaneous Medicine Vol. 6 No. 2 (2022): March Issue and Poster Presentations (FC PANP 21 and WC 22 Dermatology Conferences®) - Acne & Rosacea
Encapsulated benzoyl peroxide (E-BPO): A novel formulation of BPO for long-term management of rosacea
Abstract Poster PDF
SKIN The Journal of Cutaneous Medicine Vol. 8 No. 1 (2024): January 2024 Issue - Acne & Rosacea
Topical Clindamycin For Acne Vulgaris: Pharmacovigilance Safety Review and Retrospective Analysis of Gastrointestinal Events
Abstract PDF
SKIN The Journal of Cutaneous Medicine Vol. 7 No. 2 (2023): March Issue & Poster Presentations from WCH23 Dermatology Conference® - Skin Cancer
Impact of Actinic Keratosis (AK), as measured by patient-reported AK symptoms, and impact on emotions and functioning (using Skindex-16) among patients with AK administered tirbanibulin in real-world community practices across the U.S. (PROAK Study)
Abstract Poster PDF
SKIN The Journal of Cutaneous Medicine Vol. 7 No. 2 (2023): March Issue & Poster Presentations from WCH23 Dermatology Conference® - Skin Cancer
Investigator Global assessment (IGA) of Actinic Keratosis (AK) among patients administered tirbanibulin in real-world community practices across the U.S., and clinician likelihood to consider tirbanibulin again for future AK treatments (PROAK Study)
Abstract Poster PDF
SKIN The Journal of Cutaneous Medicine Vol. 7 No. 3 (2023): May Issue and Posters from WCH23 & WCM23 - Skin Cancer
Comparison of patient and clinician satisfaction with tirbanibulin treatment’s ability to improve ‘how skin looks’ and ‘skin texture’ in the treated area, among patients with Actinic Keratosis treated with tirbanibulin in community practices across U.S.
Abstract Poster PDF
SKIN The Journal of Cutaneous Medicine Vol. 7 No. 3 (2023): May Issue and Posters from WCH23 & WCM23 - Skin Cancer
Impact of Actinic Keratosis on patient-reported AK symptoms, emotions and functioning measured using Skindex-16, among patients with Actinic Keratosis administered tirbanibulin in real-world community practices across the U.S. (PROAK Study)
Abstract Poster PDF
SKIN The Journal of Cutaneous Medicine Vol. 5 No. 6 (2021): November Issue & Poster Presentations (FC21 Dermatology Conference®) - Acne & Rosacea
Improvements in Acne and Skin Oiliness with Tazarotene 0.045% Lotion in Acne Patients with Oily Skin
Abstract Poster PDF
SKIN The Journal of Cutaneous Medicine Vol. 7 No. 2 (2023): March Issue & Poster Presentations from WCH23 Dermatology Conference® - Acne & Rosacea
Investigator global assessment (IGA) of Acne Vulgaris and IGA Success among patients with moderate to severe non-nodular Acne Vulgaris (AV) administered sarecycline in community practices across the U.S: PROSES study analysis by gender and age
Abstract Poster PDF
SKIN The Journal of Cutaneous Medicine Vol. 6 No. 2 (2022): March Issue and Poster Presentations (FC PANP 21 and WC 22 Dermatology Conferences®) - Skin Cancer
Patient-Reported Outcomes for Tirbanibulin Effectiveness and Safety in Actinic Keratosis in Real-world Settings: PROAK Study Protocol
Abstract Poster PDF
SKIN The Journal of Cutaneous Medicine Vol. 8 No. 1 (2024): January 2024 Issue - Acne & Rosacea
Patient and Caregiver Perception of Antibiotics and Antibiotic Resistance in the Context of Managing Acne Vulgaris (AV), and Patient Global Assessment (ptGA) of AV Among Patients Administered Sarecycline in US Clinical Practices: Results from PROSES Study
Abstract PDF
SKIN The Journal of Cutaneous Medicine Vol. 8 No. 2 (2024): March 2024 Issue - Acne & Rosacea
Early Acne Improvements With Fixed-Dose Clindamycin Phosphate 1.2%/ Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel: What to Expect in the First 4 Weeks of Treatment
Abstract PDF
SKIN The Journal of Cutaneous Medicine Vol. 7 No. 3 (2023): May Issue and Posters from WCH23 & WCM23 - Acne & Rosacea
Early and Sustained Reductions in Moderate-to-Severe Acne With Fixed-Dose Clindamycin Phosphate 1.2%, Benzoyl Peroxide 3.1%, and Adapalene 0.15% Gel
Abstract Poster PDF
SKIN The Journal of Cutaneous Medicine Vol. 6 No. 6 (2022): November Issue & Poster Presentations from FC22 Dermatology Conference® - Skin Cancer
An Expert Panel Questionnaire for Assessing Patient-Reported and Clinician-Reported Outcomes in Actinic Keratosis
Abstract Poster PDF
SKIN The Journal of Cutaneous Medicine Vol. 6 No. 6 (2022): November Issue & Poster Presentations from FC22 Dermatology Conference® - Acne & Rosacea
Impact of acne on social functioning, emotional functioning, and activities of daily living among patients with moderate to severe non-nodular acne vulgaris administered sarecycline in real-world community practices across the U.S. (PROSES Study)
Abstract Poster PDF
SKIN The Journal of Cutaneous Medicine Vol. 6 No. 6 (2022): November Issue & Poster Presentations from FC22 Dermatology Conference® - Acne & Rosacea
An Expert Panel Questionnaire for Assessing Patient-Reported and Caregiver-Reported Outcomes in Acne Vulgaris
Abstract Poster PDF
SKIN The Journal of Cutaneous Medicine Vol. 7 No. 2 (2023): March Issue & Poster Presentations from WCH23 Dermatology Conference® - Acne & Rosacea
Acne symptoms and impact of acne on social functioning, emotional functioning, and activities of daily living (ADL) among pediatric patients with moderate to severe non-nodular Acne Vulgaris (AV) in community practices across the U.S: PROSES study
Abstract Poster PDF
SKIN The Journal of Cutaneous Medicine Vol. 6 No. 6 (2022): November Issue & Poster Presentations from FC22 Dermatology Conference® - Acne & Rosacea
Patient Reported Outcomes (PROs) and Investigator Global assessment (IGA) of Acne Vulgaris among patients with moderate to severe non-nodular Acne Vulgaris (AV) administered sarecycline in real-world community practices across the U.S. (PROSES Study)
Abstract Poster PDF
SKIN The Journal of Cutaneous Medicine Vol. 7 No. 6 (2023): November 2023 Issue - Atopic Dermatitis
Lebrikizumab Delivers Clinically Meaningful and Continuous Improvement in Itch-Free Days in Atopic Dermatitis Through One Year
Abstract PDF
SKIN The Journal of Cutaneous Medicine Vol. 8 No. 2 (2024): March 2024 Issue - Acne & Rosacea
Efficacy and Safety of Fixed-Dose Triple-Combination Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel for Moderate-to-Severe Acne Vulgaris in Children and Adolescents
Abstract PDF
SKIN The Journal of Cutaneous Medicine Vol. 7 No. 6 (2023): November 2023 Issue - Skin Cancer
Patient- and Clinician-Reported Outcomes of Tirbanibulin 1% in the Treatment of Actinic Keratosis on the Face and Scalp (PROAK Study)
Abstract PDF